Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies

Autor: Nakahara, Tomomi, Tsugawa, Sakiko, Noda, Yoshihiro, Ueno, Fumihiko, Honda, Shiori, Kinjo, Megumi, Segawa, Hikari, Hondo, Nobuaki, Mori, Yukino, Watanabe, Honoka, Nakahara, Kazuho, Yoshida, Kazunari, Wada, Masataka, Tarumi, Ryosuke, Iwata, Yusuke, Plitman, Eric, Moriguchi, Sho, de la Fuente-Sandoval, Camilo, Uchida, Hiroyuki, Mimura, Masaru, Graff-Guerrero, Ariel, Nakajima, Shinichiro

Publikováno v: Molecular Psychiatry; January 2022, Vol. 27 Issue: 1 p744-757, 14p

Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of ¹ H-magnetic resonance spectroscopy studies.

Autor: Nakahara T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Tsugawa S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. sakiko.tsugawa@gmail.com., Noda Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. yoshi-tms@keio.jp., Ueno F; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Honda S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Kinjo M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Segawa H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Hondo N; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Mori Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Watanabe H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Nakahara K; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Yoshida K; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada., Wada M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Tarumi R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Iwata Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Plitman E; Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., de la Fuente-Sandoval C; Laboratory of Experimental Psychiatry & Neuropsychiatry Department, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Graff-Guerrero A; Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. shinichiro_nakajima@hotmail.com.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2022 Jan; Vol. 27 (1), pp. 744-757. Date of Electronic Publication: 2021 Sep 28.